Hyperinsulinemic Normoglycemia during Cardiac Surgery Reduces a Composite of 30-day Mortality and Serious In-hospital Complications A Randomized Clinical Trial
Conclusions Intraoperative hyperinsulinemic normoglycemia reduced mortality and morbidity after cardiac surgery. Providing exogenous glucose while targeting normoglycemia may be preferable to simply normalizing glucose concentrations.
Source: Anesthesiology - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Canada Health | Clinical Trials | Insulin | Neurology | Neurosurgery | Study